Rhoda Au
Profiles

Rhoda Au, PhD

Professor, Epidemiology - Boston University School of Public Health

Biography

Dr. Au’s research interests are focused on aging and dementia, and include relating cardiovascular risk factors, brain MRI measures, and neuropathology to cognitive performance. She is also interested in merging research and technology as the path toward innovative science.

Other Positions

  • Professor, Anatomy & Neurobiology - Boston University Chobanian & Avedisian School of Medicine
  • Investigator - Framingham Heart Study
  • Member, Evans Center for Interdisciplinary Biomedical Research - Boston University
  • Graduate Medical Sciences Educator and Mentor (Primary Mentor of Graduate Students) - Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
  • Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine

Education

  • University of California, Riverside, PhD Field of Study: Psychology
  • Boston University, MBA Field of Study: Policy Analysis and Management
  • Pomona College, BA Field of Study: Psychology

Publications

  • Published on 2/22/2026

    Tao Q, Ang TFA, Huang J, Itchapurapu IS, Mez J, Alosco M, Au R, Farrer LA, Zhang X, Qiu WQ. Blood PCSK9 Impacts Alzheimer's Disease Risk in an APOE Genotype-Dependent Manner: A Prospective Cohort Study. Health Sci Rep. 2026 Feb; 9(2):e71810. PMID: 41737429.

    Read At: PubMed
  • Published on 2/10/2026

    Sun H, Ganglberger W, Nasiri S, Nassi TE, Meulenbrugge EJ, Lam AD, Zafar S, Gupta A, Ghanta M, Moura Junior VF, Shin C, Au R, Cash SS, Thomas RJ, Westover MB. Health-oriented sleep states: making sleep states reflect health conditions. Sleep. 2026 Feb 10; 49(2). PMID: 40795277.

    Read At: PubMed
  • Published on 1/13/2026

    Huang J, Rehman H, Doan C, Stein TD, Mez J, Ang TFA, Tao Q, Au R, Farrer LA, Zhang X, Qiu WQ. Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer's disease. Neurobiol Dis. 2026 Feb; 219:107257. PMID: 41539445.

    Read At: PubMed
  • Published on 1/2/2026

    Burton R, Durape S, Price E, Chien-Young K, Joshi P, Yhang E, Liu Y, Devine S, Gurnani AS, Ang TFA, Katz DI, Alosco ML, Tripodis Y, Au R, Dams-O'Connor K, Mez J. Traumatic Brain Injury and All-Cause and Dementia-Related Mortality in the Framingham Heart Study. JAMA Netw Open. 2026 Jan 02; 9(1):e2555138. PMID: 41615690.

    Read At: PubMed
  • Published on 12/19/2025

    Park S, Roth N, Barker M, Auerbach S, Perls TT, Cosentino S, Au R, Libon DJ, Sebastiani P, Andersen SL. Linguistic Features from Paragraph Recall are Markers of Cognitive Impairment. medRxiv. 2025 Dec 19. PMID: 41445597.

    Read At: PubMed
  • Published on 11/3/2025

    Marino FR, Lyu C, Li Y, Liu T, Au R, Hwang PH. Physical Activity Over the Adult Life Course and Risk of Dementia in the Framingham Heart Study. JAMA Netw Open. 2025 Nov 03; 8(11):e2544439. PMID: 41259024.

    Read At: PubMed
  • Published on 11/1/2025

    Au R, Bose N, Imam F, Kolachalama VB. Technological advances enabling an enhanced understanding of early Alzheimer's disease. Alzheimers Dement. 2025 Nov; 21(11):e70883. PMID: 41177895.

    Read At: PubMed
  • Published on 10/1/2025

    Marino FR, Rogers G, Miller JW, Selhub J, Mez J, Crane PK, Mukherjee S, Saykin AJ, Hohman TJ, Trittschuh EH, Au R, Jacques PF, Hwang PH. Higher vitamin B12 from mid- to late life is related to slower rates of cognitive decline. Alzheimers Dement. 2025 Oct; 21(10):e70864. PMID: 41152187.

    Read At: PubMed
  • Published on 9/27/2025

    Kurniansyah N, Tasaki S, Rehman H, Zhu C, Farrell J, Sherva R, Hauger R, Merritt VC, Panizzon M, Zhang R, Gaziano JM, Gim J, Lee K, Lee DY, Nho K, Vialle RA, Mukherjee S, Trittschuh EH, Lee AJ, Brickman AM, Cruchaga C, Risacher S, Greve DN, Crane P, Martin E, Bush W, Mayeux R, Haines JL, Pericak-Vance MA, Logue M, Bennett DA, Barnes LL, Saykin A, Hohman T, Wang LS, Schellenberg GC, Ang TFA, Au R, Mez J, Lunetta KL, Zhang X, Farrer LA. A multi-ancestry polygenic risk score for Alzheimer disease is associated with cognitive decline, hippocampal atrophy and neuropathological hallmarks in diverse populations. medRxiv. 2025 Sep 27. PMID: 41040715.

    Read At: PubMed
  • Published on 9/11/2025

    Christianson K, Prabhu M, Popp ZT, Rahman MS, Drane J, Lee M, Lathan C, Lin H, Au R, Sunderaraman P, Hwang PH. Adherence timescale impacts completion rates of high-frequency mobile cognitive assessments among older adults. Explor Med. 2025; 6. PMID: 41050829.

    Read At: PubMed

News & In the Media